SERETIDE DISKUS 50/100 50mg/100mg inhalation powder GLAXO SMITH KLINE
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
letter S · page 14
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol + fluticasone Indicated for: asthma; chronic obstructive pulmonary disease
salmeterol Indicated for: asthma; chronic obstructive pulmonary disease
R03AC12 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
salmeterol Indicated for: asthma; chronic obstructive pulmonary disease
R03AC12 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
sertraline Indicated for: depression; anxiety disorders
N06AB06 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
sertraline Indicated for: depression; anxiety disorders
N06AB06 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
nicergoline Indicated for: cognitive disorders; cerebral circulatory disorders
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
nicergoline Indicated for: cognitive disorders; cerebral circulatory disorders
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
nicergoline Indicated for: cognitive disorders; cerebral circulatory disorders
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
nicergoline Indicated for: cognitive disorders; cerebral circulatory disorders
C04AE02 Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Ergot alkaloids
escitalopram Indicated for: depression
N06AB10 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
escitalopram Indicated for: depression
N06AB10 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
quetiapine Indicated for: schizophrenia; bipolar disorder
N05AH04 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines